| |
PREVIOUS ISSUES
 VOLUME 6, ISSUE 4 - Winter 2012
THE IMPACT OF DRUG ABUSE ON THE MIND, BODY AND SOUL
go to this issue
 VOLUME 6, ISSUE 3 - Fall 2012
CURRENT INTERNATIONAL TRENDS IN SUBSTANCE ABUSE
go to this issue
An Updated Review of the Research on the Risks and Harms Associated to
the Use of Marijuana
Jordan Diplock, Dr. Darryl Plecas and Len Garis; Centre for Public Safety and Criminal
Justice Research, School of Criminology and Criminal Justice, University College of the Fraser Valley
Designer Drugs: An Escalating Public Health Challenge
Bertha K. Madras, PhD
 VOLUME 6, ISSUE 2 - Summer 2012
TRENDS IN SUBSTANCE ABUSE TREATMENT. PART II
go to this issue
The Use of Methadone or Naltrexone for Treatment of Opiate Dependence:
An Ethical Approach
Dr Ross Colquhoun, Doctor Health Science, Master Applied Science (Neuroscience), Bachelor
Science Honors (Psych), Graduate Diploma Counselling and Psychotherapy
Clinical Director, Addiction Treatment and Psychology Services, Australia
 VOLUME 6, ISSUE 1 - Spring 2012
TRENDS IN SUBSTANCE ABUSE TREATMENT, PART I
go to this issue
Perceptions and Use of Medical Marijuana in an Urban Substance Treatment Program
Corresponding Author: Charles Shuman M.D.
Rationale for Using Exercise in the Treatment of Stimulant Use Disorders
Tracy L. Greer, Ph.D. a; Kolette M. Ring, B.A. a; Diane Warden, Ph.D., M.B.A. a, Bruce D. Grannemann, M.A. a; Timothy S. Church, M.D., Ph.D., M.P.H. b; Eugene Somoza, M.D., Ph.D. c; Steven N. Blair P.E.D d, e; Jose Szapocznik, Ph.D.f; Mark Stoutenberg, Ph.D.f; Chad Rethorst, Ph.D. a; Robrina Walker, Ph.D.a; David W. Morris, Ph.D. a; Andrzej S. Kosinski, Ph.D. g; Tiffany Kyle, Ph.D. h; Bess Marcus, Ph.D.i; Becca Crowell, M.Ed., Ed.S. j; Neal Oden Ph.D.k; Edward Nunes, M.D. l ; Madhukar H. Trivedi, M.D. a;
a The University of Texas Southwestern Medical Center at Dallas
b Preventive Medicine Laboratory, Pennington Biomedical Research Center
c Cincinnati Addictions Research Center (CinARC); Department of Psychiatry, University of Cincinnati College of Medicine
d Department of Exercise Science, University of South Carolina
e Department of Epidemiology and Biostatistics, University of South Carolina
f Department of Epidemiology and Public Health, University of Miami, Miller School of Medicine,
g Department of Biostatistics and Bioinformatics, Duke University Medical Center, Duke Clinical Research Institute
h The Center for Drug-Free Living
i Department of Family and Preventive Medicine, The University of California, San Diego
j Nexus Recovery Center, Inc
k The EMMES Corporation
l New York State Psychiatric Institute/Department of Psychiatry, College of Physicians and Surgeons of Columbia University
 VOLUME 5, ISSUE 4 - Winter 2011
Evolution of Drug Policy, Part II
go to this issue
Employee Drug Testing: Study Shows Improved Productivity and Attendance
and Decreased Workers’ Compensation and Turnover
PNeil A. Fortner, MS, FTS-ABFT, TC-NRCC, David M. Martin, PhD, S. Evren Esen and Laura Shelton
To Schedule or Not to Schedule: How Well Do We Decide?
Jonathan P. Caulkins, Ph.D. and Carolyn Coulson, MSPPM
The Role of the Physician in “Medical" Marijuana
President’s Action Committee on Medical Marijuana of the American Society of Addiction
Medicine
Mingling Activism with Policy Influence: Harm Reduction Ideology and the
Politicisation of Canadian Drug Policy
Colin R. Mangham, PhD
 VOLUME 5, ISSUE 3 - Fall 2011
Evolution ofDrug Policy
go to this issue
The Swedish Drug Policy Experience: Past to Present
Per Johansson, Secretary General
National Association for a Drug-Free Society (RNS)
Going Dutch: drug policy developments in the Netherlands
Frans S.L. Koopmans De Hoop Foundation, Dordrecht, The Netherlands
 VOLUME 5, ISSUE 2 - Summer 2011
A Decade ofMarijuana
go to this issue
Mile High Macaroons:
The Medicalization of Marijuana in Colorado
Abraham M. Nussbaum, MD, MTS, Christian Thurstone, MD
Medical Marijuana, Nevada's Big Gamble
Todd Raybuck
The Impact of Oregon's Marijuana Program
Shirley Morgan
 VOLUME 5, ISSUE 1 - Spring 2011
International Controversies in Drug Treatment
go to this issue
The UK's Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell
The Sydney Injecting Centre - Assessing The Evidence-Base
Gary Christian
Chronic Pain Management Using Buprenorphine: Questions and Considerations
Mel Pohl, M.D, FASAM, Medical Director, Las Vegas Recovery Center, Logan Smith, B.A, Program Development Coordinator, Las Vegas Recovery Center
 VOLUME 4, ISSUES 3 - Fall 2010
Substance Abuse and the Role ofthe Court System: Problems and Policy
Solutions from Prenatal Exposure to Adulthood
go to this issue
Recreational, Reactive, and Really Bad Crimes: Uncovering the Role of Sex and Drugs in Juvenile Court
Judge Irene Sullivan
Drug Courts A Viable Solution to Drug Dependent Offenders
West Huddleston
HOPE for Probation: How Hawaii Improved Behavior with High-Probability, Low-Severity Sanctions
Angela Hawken, Ph.D., Associate Professor of Economics and Policy Analysis, School of Public Policy, Pepperdine University
A Multi-national Pre-consensus Survey: The Principles of Treatment of Substance Use Disorders during Pregnancy
Hendree E. Jones, Lucy Burns, Laurent Gourarier, Einat Peles, Marianne Springer-Kremser, and Gabriele Fischer
 VOLUME 4, ISSUES 1 and 2 - Spring/Summer 2010
Current Issues Surrounding Marijuana: The Science, the Law, the Victims
go to this issue
Early Findings in Controlled Studies of Herbal Cannabis: A Review
Andrea G. Barthwell, MD, FASAM
Pawns of Pot: The Coexistence of Marijuana and Animal Crimes
Dr. Kris Otteman DVM, Director of Shelter Medicine, Oregon Humane Society and Emily Davidsohn, Oregon Humane Society
Medical Marijuana Laws: Obstructing Congress?
Paula A. Barran, A.B. M.A., Ph.D., J.D., MBA
 VOLUME 3, ISSUE 4 - Winter 2010
go to this issue
 VOLUME 3, ISSUE 3 - FALL 2009
go to this issue
Alcohol Promotion on Facebook
Sarah Mart, Jacob Mergendoller, Michele Simon
Marin Institute, San Rafael, California, United States
Adolescent Brain Development and Alcohol Abuse
Ken C. Winters, Ph.D.
Professor, Department of Psychiatry, University of Minnesota
Senior Scientist, Treatment Research Institute
Reducing Youth Access ? The Impact of Policy Change
Michelle Voth, Executive Director, Kansas Family Partnership
 VOLUME 3, ISSUE 2 - SUMMER 2009
go to this issue
Jordan Diplock, Irwin Cohen, and Darryl Plecas School of Criminology and Criminal Justice, University College of the Fraser Valley, Abbotsford, British Columbia, Canada
 VOLUME 3, ISSUE 1 - SPRING 2009
go to this issue
A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 2
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
Barack Obama on Medical Marijuana
Robert L. DuPont, M.D.
 VOLUME 2, ISSUE 4 - WINTER 2008
go to this issue
What I Wish From Our New Administration
David A. Gross, MD, DFAPA
Cutting The Gordian Knot of Drug Addiction Confusion
Dr Stuart Reece, General Practitioner in Brisbane, Australia
Is the Glass Half Empty, Half Full or Dry?
Tavis Glassman, PhD, MPH, CHES
Afghanistan: An Enduring Problem
Ian Oliver
 VOLUME 2, ISSUE 3 - FALL 2008
Coordinating Patient Care and Predicting Alcohol Consumption: Expectations and Behavior
go to this issue
Addiction in Clinical Practice: Psychiatry
William M. Greene, MD; Mark E. Sylvester, MD; Lisa J. Merlo, PhD
Substance Abusing Patients in the Primary Care Setting: They Deserve Treatment Too
Kendall M. Campbell, MD
Emergency Medicine and Addiction Medicine: Much in Common
Daniel P. Logan, M.D., F.A.C.E.P.
Using the Theory of Planned Behavior to Predict Alcohol Consumption among College Students on Game Day
Tavis Glassman PhD, MPH, CHES, Virginia Dodd, PhD, MPH, Jiunn-Jye Sheu, PhD, MSPH, CHES, Barbara A. Rienzo, PhD, Alexander C. Wagenaar, PhD
 VOLUME 2, ISSUE 2 - SUMMER 2008
Current Issues in Drug Abuse and Treatment: Implications for Identifying Risk
go to this issue
Patterns and Characteristics of Prescription Opioid Abuse in the United States
Theodore J. Cicero, PhD1, Michael Lynskey, PhD1, Alexandre Todorov, PhD1, James Inciardi, PhD2, Hilary Surratt, PhD2
Neurobiology of Addiction and the Adolescent Brain
Deborah R. Simkin, M.D., Section Head, Division of Child and Adolescent Psychiatry, Residency Director Department of Psychiatry, University of South Alabama College of Medicine
Physicians Impaired by Substance Abuse Disorders
Kimberly B. Gold, MS4, Yale University School of Medicine, Scott A. Teitelbaum, M.D., F.A.A.P., A.S.A.M., Associate Professor, University of Florida School of Medicinen
The Use of Intervention and Case Management Models in Maximizing Recovery and Reducing Relapse Risks for Substance Abusers
Kate Caravella, CAC, NCAC 1, BRI 1
 VOLUME 2, ISSUE 1 - SPRING 2008
Prescribing Controlled Substances: A Physician's Dilemma, a Patient's Responsibility and the Public's Protection
go to this issue
Prescribing Controlled Substances Reconsidered
Eric A. Voth, M.D., FACP, Chairman, The Institute on Global Drug Policy
Thawing the Chill: The U.S. Drug Enforcement Administration, Physicians and the Controlled Substances Act
Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, DEA
Addiction Treatment: A Psychiatrist's Perspective
David A. Gross, MD, Distinguished Fellow of the American Psychiatric Association
Interventional Pain Procedures: Understanding their Role in Clinical Practice
Ian J. Kucera, M.D., Pharm.D., Director of Pain Medicine Stormont-Vail Healthcare, Topeka, KS
 VOLUME 1, ISSUE 4 - WINTER 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue
Harm Reduction the Idea and the Ideology
Professor Dr A. Hamid Ghodse, Member and Past President, INCB.
When Harm minimization is not harm minimization Australia as a Case Study
Stuart Reece MBBS (Hons), FRCS (Ed.), FRCS (Glas.), MD, FRACGP
The Local Matters: A Brief History of the Tension Between Federal Drug Laws and State and Local Policy
Kevin A. Sabet, Ph.D.
Putting ethics in its place right at the heart of drug policy debates
Dr Gregory K Pike, PhD
History of Harm Reduction - Provenance and Politics, Part 3
Peter Stoker C. Eng. ? Director, National Drug Prevention Alliance, UK
 VOLUME 1, ISSUE 3 - FALL 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue
The Effectiveness of Needle Exchange Programmes for HIV Prevention - A Critical Review
Kerstin Käll, Ulric Hermansson, Ellen J. Amundsen, Klas Rönnbäck and Sten Rönnberg
A Critical Evaluation of the Effects of Safe Injection Facilities
Garth Davies
The Public Health Dangers of Drug Abuse in Prisons
Ian Oliver
History of Harm Reduction - Provenance and Politics, Part 2
Peter Stoker C. Eng.
 VOLUME 1, ISSUE 2 - SUMMER 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue
The Lure and the Loss of Harm Reduction in UK Drug Policy and Practice
Neil McKeganey, BA, MSc, PhD, FRSA
A Critique of Canada's INSITE Injection Site and its Parent Philosophy: Implications and Recommendations for Policy Planning
Colin Mangham, PhD
Is It Harm Reduction - Or Harm Continuation?
Peter O'Loughlin
History of Harm Reduction Provenance and Politics, Part 1
Peter Stoker C. Eng.
 VOLUME 1, ISSUE 1 - SPRING 2007
Marijuana: The present challenge and the future of cannabinoid research
go to this issue
Marijuana and cannabinoid research: Current status and future potential
Eric A. Voth, MD, FACP
From Mockery to Medicine: The Story of the Development of a Serious Modern Medicine
Andrea G. Barthwell, MD, FASAM
Marijuana and Adolescents
Edward A. Jacobs, MD, FAAP
|
|
|
